MARTIN ANDREANSKY to Humans
This is a "connection" page, showing publications MARTIN ANDREANSKY has written about Humans.
Connection Strength
0.081
-
Rehabilitation and physical activity for COVID-19 patients in the post infection period. Bratisl Lek Listy. 2021; 122(5):310-314.
Score: 0.018
-
Intra-Arterial Platelet Infusion for Intractable Hemorrhage and Refractory Thrombocytopenia in Children With Gastrointestinal Graft-Versus-Host Disease. Pediatr Blood Cancer. 2015 Dec; 62(12):2226-8.
Score: 0.013
-
Bronchoscopic instillation of activated recombinant factor VII to treat diffuse alveolar hemorrhage in a child. Pediatr Pulmonol. 2010 Apr; 45(4):411.
Score: 0.009
-
Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy. Transplant Cell Ther. 2025 Oct; 31(10):826.e1-826.e10.
Score: 0.006
-
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. Am J Hematol. 2024 04; 99(4):785-788.
Score: 0.006
-
Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease. Transplant Cell Ther. 2022 03; 28(3):174.e1-174.e5.
Score: 0.005
-
Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients. Biol Blood Marrow Transplant. 2019 03; 25(3):556-561.
Score: 0.004
-
Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial. Biol Blood Marrow Transplant. 2018 06; 24(6):1216-1222.
Score: 0.004
-
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood. 2016 11 24; 128(21):2561-2567.
Score: 0.003
-
Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies. Am J Hematol. 2015 Dec; 90(12):1093-8.
Score: 0.003
-
Outcomes after hematopoietic stem cell transplantation for children with I-cell disease. Biol Blood Marrow Transplant. 2014 Nov; 20(11):1847-51.
Score: 0.003
-
Acute necrotizing ulcerative gingivitis and bacteremia caused by Stenotrophomonas maltophilia in an immunocompromised host. Pediatr Infect Dis J. 2005 Feb; 24(2):181-3.
Score: 0.002
-
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia. 2004 Apr; 18(4):676-84.
Score: 0.001
-
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse. Leukemia. 2004 Mar; 18(3):499-504.
Score: 0.001
-
Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia. Br J Haematol. 2003 Oct; 123(2):243-52.
Score: 0.001
-
Successful treatment of disseminated fusariosis. Bone Marrow Transplant. 2003 Mar; 31(5):411-2.
Score: 0.001